Khokon Miah Akanda: 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke
Khokon Miah Akanda, Senior Brand Executive at Apex Pharma Limited, shared on LinkedIn:
“Major Updates in Stroke Care: 2026 AHA/ASA Guidelines Released Today
The American Heart Association and American Stroke Association have released the 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. These updates represent significant shifts in prehospital triage, thrombolytic choices, and post-procedural management.
Key Takeaways for Clinicians and Industry Leaders:
• Tenecteplase is Mainstream: The guidelines now endorse Tenecteplase (0.25 mg/kg) as a reasonable alternative to Alteplase for eligible patients within the 4.5-hour window.
• Expanded EVT Eligibility: Endovascular Thrombectomy (EVT) is now strongly recommended for select patients with large ischemic core strokes and basilar artery occlusions.
• Prehospital Triage: New emphasis on direct transport to EVT capable centers for suspected Large Vessel Occlusion (LVO), bypassing smaller centers when appropriate logistics exist.
• Pediatric Care: For the first time, guidelines include specific recommendations for endovascular treatment in children.
Management Shifts
Mild Stroke: Routine IV thrombolysis is not recommended for non-disabling deficits; Dual Antiplatelet Therapy (DAPT) is preferred.
Blood Pressure: Intensive lowering (<140 mm Hg) immediately post-reperfusion is not recommended and may be harmful.
Glycemic Control: Intensive glucose control between (80-130 mg/dL) is advised against due to hypoglycemia risk.
These guidelines push for faster, more precise interventions and open new doors for therapeutic options.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy